EIF4EBP1 and cancer: Human cancer cell lines showed co-amplification of FGFR1-4EBP1 (6–9%), and this was mutually exclusive with PI3K mutations observed in 20% of the samples in Cell Line Encyclopedia (Supplementary Figure S2A).